Compare SPRY & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRY | SCZM |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Canada |
| Employees | N/A | 455 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.5M | 585.2M |
| IPO Year | 2020 | N/A |
| Metric | SPRY | SCZM |
|---|---|---|
| Price | $5.62 | $9.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $40.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.5M | 486.0K |
| Earning Date | 05-11-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $84,278,000.00 | N/A |
| Revenue This Year | $87.40 | $79.38 |
| Revenue Next Year | $81.64 | N/A |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.91 | $5.61 |
| 52 Week High | $13.15 | $17.65 |
| Indicator | SPRY | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 67.43 |
| Support Level | $5.04 | $8.64 |
| Resistance Level | $6.58 | $12.81 |
| Average True Range (ATR) | 0.37 | 0.60 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 35.14 | 82.05 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapa mine and processing plant, and Corporate and Other activities. Key revenue is generated from Zimapan.